3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Endodermal Sinus Tumor
1
Central Nervous System Neoplasms
1
Castrate Resistant Prostate Cancer
1
Interventions
Filgrastim
10
Carboplatin
10
Ifosfamide
9
Paclitaxel
8
Peripheral Blood Stem Cell Transplantation
7
Etoposide
7
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Thiotepa
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Cisplatin
4
Busulfan
4
Biopsy
4
pegfilgrastim
3
etoposide phosphate
3
Temozolomide
3
Granulocyte Colony-Stimulating Factor
3
tazemetostat
2
olaparib
2
larotrectinib
2
ixabepilone
2
erdafitinib
2
ensartinib
2
Vemurafenib
2
Stem Cell Transplantation
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Lenograstim
×
Genitourinary
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled